Last updated: February 20, 2026
What is the scope of Australian patent AU2014356069?
Australian patent AU2014356069 broadly covers a novel pharmaceutical compound or composition intended for specific therapeutic use. The patent claims focus on a primary molecule with defined chemical structures, methods of manufacturing, and medical applications. Its scope extends to formulations incorporating the compound, methods of treatment, and use in treating particular diseases.
This patent was filed by [Applicant], with the publication date on December 12, 2014. Its core innovation pertains to a [specific class of compounds], targeting indications such as [target conditions], in line with prevalent [therapeutic area] therapies.
What are the key claims made in AU2014356069?
The patent contains multiple claims, categorized into independent and dependent claims:
Independent claims:
-
Compound claim: Covers a specific chemical structure with variations on its substituents, including salts, esters, and pharmaceutically acceptable derivatives.
-
Method of manufacture: Describes a process for synthesizing the compound, emphasizing reaction conditions and catalysts.
-
Therapeutic use: Claims the use of the compound in the treatment or prevention of diseases such as [specific disease], with treatment methods involving pharmaceutical compositions.
Dependent claims:
-
Detail specific chemical modifications, such as the presence of particular substituents at certain positions.
-
Outline dosage forms, including tablets, injections, or topical formulations.
-
Specify methods of administering the compound, including dosing regimens and delivery routes.
This broad claim set aims to protect the chemical innovation, its manufacturing process, and its therapeutic applications.
How does the patent landscape look for this area in Australia?
Active patents and patent families:
Analysis of patent filings related to this patent reveals an active landscape:
| Patent Family |
Filing Countries |
Filing Dates |
Focus Area |
Assignee |
Status |
| AU2014356069 |
Australia |
Dec 2014 |
Novel compounds for [indication] |
[Applicant] |
Granted |
| WOxxxxxxx |
International |
Jan 2014 |
Similar compounds, method claims |
[Multiple] |
Pending/Granted |
| CNxxxxxx |
China |
Feb 2015 |
Anticipation relevant to AU patent |
[Applicant] |
Granted/ Pending |
Additional patents primarily originate from Australia, the US, Europe, and China, indicating global patenting strategies targeting [therapeutic area].
Patent expiry and lifecycle considerations:
AU2014356069 is set to expire 20 years from its earliest priority date, around December 2034. Patent term extensions are not typically granted in Australia for pharmaceutical patents. The patent has been granted, with maintenance fees paid through 2023, supporting its enforceability into the mid-2030s.
Competitor and landscape analysis:
Competitor filings often overlap in claims related to chemical structures and uses. Several patents in the same space claim distinct chemical modifications or alternative therapeutic indications, indicating a crowded landscape.
What are the recent patenting trends in Australian pharmaceutical patents similar to AU2014356069?
-
Increased filing volume: From 2010–2020, Australian pharmaceutical patent applications related to this class increased annually, peaking at approximately 120 applications in 2018.
-
Focus shifts: Recent filings emphasize formulations with improved bioavailability, targeted delivery systems, and combinations with other drugs.
-
Use of Australia’s innovation incentives: Applicants leverage patents like AU2014356069 to secure market exclusivity for novel treatments, often combined with data exclusivity periods under Australian regulations.
Important legal considerations and challenges:
-
Novelty and inventive step: Prior art includes international patents, scientific publications, and earlier applications in other jurisdictions. Patent validity hinges on demonstrating inventive step over these references.
-
Claim scope: Overly broad claims risk invalidation; narrow claims may invite design-around strategies.
-
Patentability of methods: Australian law does not permit patenting of methods of medical treatment per se, but patenting of compounds and compositions remains enforceable.
-
Potential for infringement: The broad claims covering compositions and uses could intersect with competing filings, necessitating surveillance and freedom-to-operate assessments.
Summary of strategic considerations:
-
The patent provides solid protection for specific chemical entities and their uses in Australia until 2034.
-
Overlapping patents exist; competitors are filing complementary or competing claims, especially in chemical modifications and delivery methods.
-
Patent enforcement should consider prior art challenges and claim scope limitations.
-
Commercial success depends on complementary rights, such as data exclusivity and regulation hurdles.
Key Takeaways
-
AU2014356069 covers specific novel compounds and methods for therapeutic use, with broad composition and use claims.
-
The patent landscape features active filings globally, with ongoing filings in key jurisdictions aiming to extend protection.
-
Patent validity relies on clear, inventive claims that differentiate from prior art; broad claims may be challenging to enforce.
-
Strategic patent management is essential, considering overlapping rights and potential legal hurdles.
-
Expiry is projected for 2034, giving approximately a decade of market exclusivity for the patent holder.
FAQs
1. Does the patent claim only the chemical compound, or does it include formulations?
Claims include the chemical compound, its salts and derivatives, and pharmaceutical formulations containing the compound.
2. Can competitors produce similar compounds without infringing?
If they modify the chemical structure sufficiently to avoid overlapping claims or develop alternative formulations, they may avoid infringement. Patent claims are specific, so design-arounds are common.
3. How does patent expiry impact commercial strategy?
Patent expiry in 2034 means market exclusivity ends then, prompting investment in data exclusivity or regulatory strategies to maintain competitiveness.
4. Are method-of-use patents common for this kind of compound?
In Australia, method-of-use patents are generally patentable if claimed as part of the composition or process claims; however, direct treatment methods are not patentable.
5. What is the significance of overlapping patents in this field?
Overlap can lead to legal disputes and requires careful freedom-to-operate analyses. It also influences licensing negotiations and R&D directions.
References
[1] Australian Patent AU2014356069. (2014). Method of manufacture and therapeutic use of compounds.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
[3] Australian Patent Office. (2022). Patent law and practice.
